Moreover, findings from Wang et al. [19] showed that ARL3 is downregulated and functions as a prognostic biomarker in glioma, suggesting its potential involvement in antiangiogenesis and the invasion of immune cells within the tumor tissue environment. The gene discussed is ARL3; the disease is neoplasm.